Get the weekly note

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

VOE vs XLV: how they differ

VOE and XLV hold 7% of their weight in the same names.

Vanguard Mid-Cap Value Index Fund and State Street(R) Health Care Select Sector SPDR(R) ETF.

What they hold in common

By the books each fund has filed, VOE and XLV hold 7% of their money in the same securities at the same weight.

Positions VOE and XLV both hold, largest shared weight first
HoldingVOEXLV
Cardinal Health Inc0.96%0.97%
Cencora Inc0.91%0.96%
Humana Inc0.83%0.83%
Becton Dickinson & Co0.72%0.73%
IQVIA Holdings Inc0.56%0.56%
Regeneron Pharmaceuticals Inc0.56%1.09%
Biogen Inc0.55%0.56%
GE HealthCare Technologies Inc0.51%0.51%
Quest Diagnostics Inc0.41%0.41%
Labcorp Holdings Inc0.40%0.40%
Centene Corp0.28%0.53%
Zimmer Biomet Holdings Inc0.14%0.29%
Largest positions each one holds and the other does not
Only in VOEOnly in XLV
Cummins Inc 1.71%Eli Lilly & Co 16.56%
Valero Energy Corp 1.34%Johnson & Johnson 10.67%
Marathon Petroleum Corp 1.29%AbbVie Inc 7.76%
CRH PLC 1.24%UnitedHealth Group Inc 6.59%
United Rentals Inc 1.23%Merck & Co Inc 5.54%
General Motors Co 1.21%Amgen Inc 3.41%
SLB Ltd 1.21%Thermo Fisher Scientific Inc 3.25%
Simon Property Group Inc 1.20%Abbott Laboratories 2.76%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.

VOE and XLV on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
VOE
Vanguard Mid-Cap Value Index Fund
XLV
State Street(R) Health Care Select Sector SPDR(R) ETF
Where it sitsCore index fundCore index fund
IssuerVanguardState Street
What it isMid-Cap ValueHealth care
Total return, 1 year+20.2%+20.4%
S&P 500 over the same days+17.5%+17.5%
Gap to the S&P 500+2.7 pts+2.9 pts
Expense ratio0.05%0.08%
Already in the S&P 50096.6%100.0%
Holdings17059

VOE in plain words

VOE is an index equity fund tracking the Mid-Cap Value. Over the year to Sep 11, 2026 it returned +20.2% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.05% a year. By its holdings filed for Jun 30, 2026, 97% of the fund by weight is stocks the S&P 500 also holds, across 170 positions, with the top ten at 12.7%.

XLV in plain words

XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, VOE or XLV?
In the year to Sep 12, 2026, with distributions reinvested, VOE returned +20.2% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
Which is cheaper, VOE or XLV?
VOE charges 0.05% a year and XLV charges 0.08%, so VOE is cheaper. Fees come from each fund's prospectus.
How much do VOE and XLV overlap with the S&P 500?
By their latest filed holdings, 97% of VOE and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 7% of their books are the same securities at the same weight.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

VOE against XLV, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, VOE against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/VOE-XLV Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources